KalVista Pharmaceuticals (KALV) EBT Margin (QoQ) (2014 - 2025)
KalVista Pharmaceuticals (KALV) EBT Margin (QoQ) (2014 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,102.16 Bn | 67,101.87 Bn | - |
| 2 | Nanobiotix | 1,908.96 Bn | 1,908.90 Bn | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - |
| 4 | BeOne Medicines | 474.03 Bn | 469.24 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.13 Bn | 114.88 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.09 Bn | 61.34 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.34 Bn | 62.34 Bn | - |
| 8 | Argenx Se | 55.96 Bn | 50.77 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.53 Bn | 34.52 Bn | 959.66 Mn |
| 10 | KalVista Pharmaceuticals | 1.36 Bn | 1.36 Bn | 49.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 31, 2025 | 36,668.00 |
| Apr 30, 2020 | 72,370.00 |
| Jan 31, 2020 | -64,543.00 |
| Oct 31, 2019 | 1,319.00 |
| Jul 31, 2019 | 8,985.00 |
| Apr 30, 2019 | -21,706.00 |
| Jan 31, 2019 | -7,138.00 |
| Oct 31, 2018 | 10,527.00 |
| Jul 31, 2018 | -13,492.00 |
| Apr 30, 2018 | 13,550.00 |
| Jan 31, 2018 | 35,118.00 |
| Oct 31, 2017 | 566,583.00 |
| Jul 31, 2017 | -175,405.00 |
| Apr 30, 2017 | -118,829.00 |
| Jan 31, 2017 | -123,209.00 |
| Oct 31, 2016 | -151,438.00 |
| Mar 31, 2016 | -2.15 Mn |
| Dec 31, 2015 | -185,714.00 |
| Sep 30, 2015 | 512,857.00 |
| Jun 30, 2015 | -211,429.00 |